Last Week, the Government Accountability Office (GAO) released an 80-page Report to Congressional Committees (full text) titled DEA Should Improve its Religious Exemptions Petition Process for Psilocybin (Mushrooms) and Other Controlled Substances. The Report says in part:
Selected stakeholders reported several barriers to the legal access and use of psilocybin for religious practices under the Religious Freedom Restoration Act. For example, DEA established a process for parties to petition for a religious exemption from the Controlled Substances Act to use controlled substances for religious purposes. However, DEA’s guidance does not inform petitioners on its timeframes to make determinations on completed petitions. DEA officials stated the agency is aware of public concerns on the need to better understand its policies and processes that impact the petitions for religious exemptions. In 2019, DEA initiated a draft notice of proposed rulemaking related to its process for petitioning for religious exemptions. Four years later, in February 2023, the final draft notice was submitted to DEA’s Office of the Administrator, according to DEA officials; but there is no timeframe for issuance of the notice or final regulations....
Including timeframes to make determinations about religious exemption petitions in DEA’s guidance will provide better transparency about the agency’s process.
Filter has additional details.
